GOSH Conference 2020 - Our People • Our Patients • Our Hospital

4 Dec 2020, 10 a.m.

Our 4th annual GOSH conference was run virtually and delivered successfully by the GLA team on Friday, 20th November.

The themes of this year’s conference were Our patients, Our people and Our hospital.

GOSHConf_Themes

We had over 547 participants logged onto our conference. The day started with inspirational talk from GOSH’s YPF Governor Miss Grace Shaw-Hamilton, followed by RCPCH President, Prof. Russell Viner. The morning sessions went on to cover a broad width of topics around wellbeing, Culture Intelligence, Guarding our reputation, and much more. The day finished with ‘Green Hospital’, presented by Dr Nicholas Boyd, Consultant Anaesthetist, Bristol Children Hospital and Nick Martin, Sustainability Lead.

Congratulations to our Oral presentation winner Ms Helen Mercer and Digital poster winner Mr Dulanka Silva and their teams. We accepted a total 116 abstracts which represented a huge diversity of works have been done by our people and they will be published on the Archive of Childhood Disease.

Thank you all who have attended the conference and all the internal and external speakers who have made the day Informative and fabulous

GOSHConf_Keynote Speakers

GOSH Consultant, Dr Emma Clement, joins the North Thames Genomic Medicine Service

Dr Emma Clement has joined the NT GMS as Deputy Medical Director.

Fifth annual 'Moment of Discovery' image competition open 5-18 January

The annual Research and Innovation Image Competition, A Moment of Discovery, is back for the fifth year and open for entries between 5-18 January 2026.

Arsenal stars bring festive cheer to patients, families and staff

GOSH was buzzing with excitement this month as players from Arsenal’s men’s and women’s first‑team squads paid a special visit to children, families, and staff.

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.